A Prospective Phase 2 Trial of Reirradiation With Stereotactic Body Radiation Therapy Plus Cetuximab in Patients With Previously Irradiated Recurrent Squamous Cell Carcinoma of the Head and NeckJohn A. Vargo, Dwight E. Heron, Robert L. Ferris et al.|International Journal of Radiation Oncology*Biology*Physics|2015Cited by 156
Accuracy of Computed Tomography in the Prediction of Extracapsular Spread of Lymph Node Metastases in Squamous Cell Carcinoma of the Head and NeckRaymond L. Chai, Barton F. Branstetter, Tanya J. Rath et al.|JAMA Otolaryngology–Head & Neck Surgery|2013Cited by 104
Transition to a virtual multidisciplinary tumor board during the <scp>COVID</scp>‐19 pandemic: University of Pittsburgh experienceHarish Dharmarajan, Mark Kubik, Robert L. Ferris et al.|Head & Neck|2020Cited by 88
Risk of Severe Toxicity According to Site of Recurrence in Patients Treated With Stereotactic Body Radiation Therapy for Recurrent Head and Neck CancerDiane C. Ling, Dwight E. Heron, John A. Vargo et al.|International Journal of Radiation Oncology*Biology*Physics|2016Cited by 70
Negative Predictive Value of Surveillance PET/CT in Head and Neck Squamous Cell CancerM. McDermott, Barton F. Branstetter, Marion A. Hughes et al.|American Journal of Neuroradiology|2013Cited by 65